Factor V (FV) has been isolated in homogenous form and converted from a single chain precursor protein (Mr equals 300,000) to Factor Va (FVa) (2 chains, Mr equals 115,000 and Mr equals 73,000) by limited proteolysis with thrombin. A two chain activation intermediate (FVi) (Mr equals 220,000 and 115,000) has been isolated and methods have been developed to isolate chains of both the FVi and FVa. We propose to determine the position of these chains within the FV molecule by partial amino terminal sequencing of each of the above chains. The FVa subunits have been separated by ion exchange chromatography in the presence of EDTA. Reformation of the complex with concomitant regeneration of FV activity has been obtained by incubation of the subunits in the presence of Mn2 plus or Ca2 plus. The ion binding capability of the FV, FVi, and FVa and each of the subunits will be evaluated by flow dialysis in the presence of 54Mn or 45Ca. From an evaluation of the affinity and number of ion binding sites in each of these species of FV it should be possible to gain insight into the role of these cations in maintaining the subunit-subunit interaction. Immunological properties of the subunits will be characterized in the presence and absence of Ca2 plus. Guanidino benzoate Factor Xa (GB-Xa) retains its capacity to activate prethrombin-2, but not prothrombin. GB-Xa, re-isolated from prethrombin-2 incubation mixtures, will not catalyze prothrombin activation. We propose to calculate the rate of 14CGB release from the FXa during the incubation with prethrombin-2. The kinetics of the release of the label from FXa should allow a direct demonstration of whether the deacylation rate is sufficient to allow the observed catalysis. This experiment will be repeated in the presence of FVa plus or minus fragment 2 (both of which accelerate GB-Xa activation of prethrombin-2) in order to deterimine if the deacylation rate under these conditions is adequate to account for the rate of prethrombin-2 activation observed. Finally, we will investigate the rate of 14CGB incorporation into prethrombin-2 in the presence of GB-Xa plus or minus FVa plus or minus fragment 2 to determine which, if any, of these factors facilitate formation of a catalytic site in prethrombin-2.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL029807-04
Application #
3340867
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1982-06-01
Project End
1985-12-31
Budget Start
1985-01-01
Budget End
1985-12-31
Support Year
4
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Oklahoma Medical Research Foundation
Department
Type
DUNS #
937727907
City
Oklahoma City
State
OK
Country
United States
Zip Code
73104
Cooper, Scott T; Rezaie, Alireza R; Esmon, Charles T et al. (2002) Inhibition of a thrombin anion-binding exosite-2 mutant by the glycosaminoglycan-dependent serpins protein C inhibitor and heparin cofactor II. Thromb Res 107:67-73
Yegneswaran, S; Smirnov, M D; Safa, O et al. (1999) Relocating the active site of activated protein C eliminates the need for its protein S cofactor. A fluorescence resonance energy transfer study. J Biol Chem 274:5462-8
Yegneswaran, S; Wood, G M; Esmon, C T et al. (1997) Protein S alters the active site location of activated protein C above the membrane surface. A fluorescence resonance energy transfer study of topography. J Biol Chem 272:25013-21
Ye, J; Esmon, C T (1995) Factor Xa-factor Va complex assembles in two dimensions with unexpectedly high affinity: an experimental and theoretical approach. Biochemistry 34:6448-53
Rezaie, A R; Esmon, C T (1995) Contribution of residue 192 in factor Xa to enzyme specificity and function. J Biol Chem 270:16176-81
Rezaie, A R; Esmon, C T (1995) Tryptophans 231 and 234 in protein C report the Ca(2+)-dependent conformational change required for activation by the thrombin-thrombomodulin complex. Biochemistry 34:12221-6
Esmon, C T (1995) Inflammation and thrombosis: the impact of inflammation on the protein C anticoagulant pathway. Haematologica 80:49-56
Esmon, C T; Fukudome, K (1995) Cellular regulation of the protein C pathway. Semin Cell Biol 6:259-68
Rezaie, A R; Cooper, S T; Church, F C et al. (1995) Protein C inhibitor is a potent inhibitor of the thrombin-thrombomodulin complex. J Biol Chem 270:25336-9
Esmon, C T (1995) Thrombomodulin as a model of molecular mechanisms that modulate protease specificity and function at the vessel surface. FASEB J 9:946-55

Showing the most recent 10 out of 71 publications